By: William Newton
A Pennsylvania federal judge has once again dismissed a hospital lawsuit alleging that CVS Health illegally tied its 340B contract [...]


William Newton is a Senior Healthcare Reporter at 340B Report. He specializes in healthcare journalism with a focus on drug pricing policy, patient care, and public health, while also exploring themes in law, politics, and the intersection of arts and healthcare. His work has been featured in Clinical Trials Arena, The Spectator World, Yahoo Finance, Berkeleyside, BioRxiv, and SALINA GUNS AND HOSES.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
William Newton's coverage is heavily focused on the healthcare and pharmaceutical industry, particularly clinical trials, drug development, and disease-specific research. He frequently cites data and press releases to support his articles.
Given this focus, William may be most receptive to pitches that offer access to exclusive data or insights from experts in the pharmaceutical industry. Pitches related to breakthroughs in drug development, innovative approaches to clinical trials such as decentralized trials, and advancements in treating specific diseases like Alzheimer's or epilepsy are likely to align with his coverage interests.
If you have relevant data or expertise within the pharmaceutical industry or specific disease areas covered by William, your pitch could resonate well with him.
This information evolves through artificial intelligence and human feedback. Improve this profile .